Please login to the form below

Not currently logged in

Wilson Therapeutics

This page shows the latest Wilson Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Alexion adds to pipeline rebuild with $855m Wilson buy

Alexion adds to pipeline rebuild with $855m Wilson buy

Alexion Pharma’s drive to reduce its reliance on cash cow Soliris has gone up a gear with a $855m offer for rare disease company Wilson Therapeutics. ... Ludwig Hantson, Alexion’s chief executive, said: “The acquisition of Wilson Therapeutics is a

Latest news

  • mRNA - message received mRNA - message received

    Arcturus Therapeutics. thrombopoietin; alpha-1 antitrypsin replacment; cystic fibrosis; iron disorders. Tekmira, Arrowhead. ... Shire. Eukarys. monogenic liver diseases; Wilson disease. Moderna Therapeutics. cancer; cardiovascular disease; infectious

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest appointments

  • IGEM Therapeutics appoints Dr Tim Wilson as CEO IGEM Therapeutics appoints Dr Tim Wilson as CEO

    IGEM Therapeutics appoints Dr Tim Wilson as CEO. He joins after the UK immuno-oncology firm raises £2m to advance its pipeline. ... Wilson has over 28 years’experience in the life sciences sector, ranging from venture capital and start-ups to

  • Therachon strengthens management team Therachon strengthens management team

    He currently serves as chairman of Asceneuron, Complix and InteRNA, and as a non-executive director at Hansa Medical, Sobi, Wilson Therapeutics and Dutch Top Sector Life Sciences and Health.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
An agency called Owen

We’re an independent brand and marketing agency that believes our DNA is a little different from others. * A respectful,...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...